CORRECTED-UPDATE 1-Regeneron-Sanofi drug succeeds mid-stage study
October 16, 2017 at 18:16 PM EDT
Oct 16 (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.